Living With Primary Ciliary Dyskinesia (Living With PCD)

NCT04602481 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-12-02

No results posted yet for this study

Summary

Living with PCD (formerly COVID-PCD) is a participatory research project that aims to answer emerging questions about primary ciliary dyskinesia (PCD) in order to improve the health and quality of life of people with PCD. Persons with confirmed or suspected PCD from anywhere in the world can participate. The study is advertised through patient support groups and participants register online after they read detailed information about the study. Participants receive a detailed questionnaire when they start the study and a follow-up questionnaire (planned once per year). Occasionally, participants receive extra questionnaires focused on special topics. The study is hosted at the University of Bern and recruitment started on May 30th, 2020.

Conditions

  • Primary Ciliary Dyskinesia

Sponsors & Collaborators

  • Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesie

    collaborator UNKNOWN
  • Verein Kartagener Syndrom und PCD

    collaborator UNKNOWN
  • PCD Support UK

    collaborator UNKNOWN
  • PCD Foundation

    collaborator UNKNOWN
  • PCD Australia

    collaborator UNKNOWN
  • European Lung Foundation

    collaborator UNKNOWN
  • University of Southampton

    collaborator OTHER
  • Universität Luzern

    collaborator OTHER
  • Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kargagener APS

    collaborator UNKNOWN
  • Asociación Nacional de Pacientes con Discinesia Ciliar Primaria

    collaborator UNKNOWN
  • Association Dyskinésie Ciliaire Primitive ADCP

    collaborator UNKNOWN
  • University of Bern

    lead OTHER

Principal Investigators

  • Claudia E Kuehni, Prof. · University of Bern

  • Myrofora Goutaki, Prof · University of Bern

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-31
Primary Completion
2030-05-31
Completion
2030-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04602481 on ClinicalTrials.gov